MEPs approve plans for European CDC

A European CDC?

European Project for Rare Diseases National Plans Development (EUROPLAN)

EUROPLAN (http://www.europlanproject.eu) is a three year EU funded project (2008-2011) coordinated by the Italian National Centre for Rare Diseases (Istituto Superiore di Sanità, Italy), which involves 30 Countries and EURORDIS. The Council Recommendations on European Action in the field of Rare Diseases (RD) which was adopted by the EU Council in June 2009 calls upon Member States to adopt Nat...

Oral Medicines for Children in the European Paediatric Investigation Plans

INTRODUCTION Pharmaceutical industry is no longer allowed to develop new medicines for use in adults only, as the 2007 Paediatric Regulation requires children to be considered also. The plans for such paediatric development called Paediatric Investigation Plans (PIPs) are subject to agreement by the European Medicines Agency (EMA) and its Paediatric Committee (PDCO). The aim of this study was t...

Segmentation and Clustering of MEPs

Why Did the FDA Approve These Advertisements?

David Oaks I would like to thank PLoS Medicine for publishing Lacasse and Leo’s important and methodical Essay that debunks the “chemical imbalance” advertisements for psychiatric drugs [1]. Why would the United States Food and Drug Administration (FDA) approve such ads? Our human rights group, MindFreedom International, has been asking that question for a long time. On behalf of MindFreedom, U...